Harms and Contributors of Leaving Against Medical Advice in Patients With Infective Endocarditis

Ajay Kumar Mishra1, Benson M Abraham2, Kamal K Sahu3

  • 1From the Division of Cardiology, Department of Medicine, Saint Vincent Hospital, Worcester.

Insights

Infective endocarditis patients leaving against medical advice (AMA) are often younger females with higher comorbidities like drug use and prior IE. These patients experience increased morbidity, including embolic events and recurrent admissions.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Leaving against medical advice (AMA) is a significant issue in hospital medicine globally.
  • Infective endocarditis (IE) poses unique challenges when patients leave treatment prematurely.

Purpose of the Study:

  • To investigate the demographic, clinical, and laboratory profiles of IE patients who leave AMA.
  • To compare risk factors and outcomes of IE patients leaving AMA versus those completing treatment.

Main Methods:

  • Retrospective study analyzing 111 patients diagnosed with IE over 36 months.
  • Detailed comparison of 32 patients leaving AMA with those who completed therapy.

Main Results:

  • Patients leaving AMA were younger (mean age 39), predominantly female (66%), and had higher rates of injection drug use (68.1%), prior IE (83.3%), and chronic hepatitis C (72.4%).
  • Higher psychiatric comorbidities (63%), history of leaving AMA (70.5%), and substance abuse were noted in the AMA group.
  • Patients leaving AMA experienced significantly higher morbidity, including distal emboli, recurrent admissions, and recurrent bacteremia.

Conclusions:

  • IE patients leaving AMA are typically younger females with substantial comorbidities including substance abuse and psychiatric issues.
  • Leaving AMA is associated with increased morbidity, such as embolic events and recurrent hospitalizations.
  • Addressing socioeconomic factors and comorbidities is crucial for improving treatment adherence in IE patients.
Abstract

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
15
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
25
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
25
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
23
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
19